BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 7035692)

  • 1. Oxalate metabolism and renal calculi.
    Menon M; Mahle CJ
    J Urol; 1982 Jan; 127(1):148-51. PubMed ID: 7035692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxalate and renal stone formation.
    Tiselius HG
    Scand J Urol Nephrol Suppl; 1980; 53():135-48. PubMed ID: 6937989
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxalate synthesis, transport and the hyperoxaluric syndromes.
    Williams HE; Wandzilak TR
    J Urol; 1989 Mar; 141(3 Pt 2):742-9. PubMed ID: 2645433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate.
    Marangella M; Fruttero B; Bruno M; Linari F
    Clin Sci (Lond); 1982 Oct; 63(4):381-5. PubMed ID: 7105633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease.
    Schwille PO; Hanisch E; Scholz D
    J Urol; 1984 Oct; 132(4):650-5. PubMed ID: 6471206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of increased oxalate absorption in patients with calcium-containing renal stones.
    Hodgkinson A
    Clin Sci Mol Med; 1978 Mar; 54(3):291-4. PubMed ID: 630804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.
    Lindsjö M; Danielson BG; Fellström B; Ljunghall S
    Scand J Urol Nephrol; 1989; 23(1):55-9. PubMed ID: 2922580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal absorption of oxalate and calcium in patients with jejunoileal bypass.
    Lindsjö M; Danielson BG; Fellström B; Lithell H; Ljunghall S
    Scand J Urol Nephrol; 1989; 23(4):283-9. PubMed ID: 2595324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium oxalate nephrolithiasis: defective oxalate transport.
    Borsatti A
    Kidney Int; 1991 Jun; 39(6):1283-98. PubMed ID: 1895680
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
    Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of magnesium on the absorption and excretion of calcium and oxalate ions.
    Berg W; Bothor C; Pirlich W; Janitzky V
    Eur Urol; 1986; 12(4):274-82. PubMed ID: 3743598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
    Laminski NA; Meyers AM; Kruger M; Sonnekus MI; Margolius LP
    Br J Urol; 1991 Nov; 68(5):454-8. PubMed ID: 1747716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental and clinical studies on calcium urolithiasis: (I) Animal model for calcium oxalate urolithiasis using ethylene glycol and 1-alpha (OH) D3].
    Okada Y; Kawamura J; Nonomura M; Kuo YJ; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):565-77. PubMed ID: 4036734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Okawa T
    Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.